Study design features that improve effect sizes in cross-sectional and longitudinal brain-wide association studies

Kaidi Kang,Jakob Seidlitz,Richard A.I. Bethlehem,Jiangmei Xiong, Megan T. Jones, Kahini Mehta, Arielle S. Keller,Ran Tao, Anita Randolph, Bart Larsen, Brenden Tervo-Clemmens, Eric Feczko, Oscar Miranda Dominguez, Steve Nelson, Lifespan Brain Chart Consortium, R-BRAIN, AIBL, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Repository Without Borders Investigators, CALM Team, CCNP, COBRE, cVEDA, Harvard Aging Brain Study, IMAGEN, POND, The PREVENT-AD Research Group,Jonathan Schildcrout, Damien Fair, Theodore D. Satterthwaite,Aaron Alexander-Bloch,Simon Vandekar

biorxiv(2024)

引用 2|浏览3
暂无评分
摘要
Brain-wide association studies (BWAS) are a fundamental tool in discovering brain-behavior associations. Several recent studies showed that thousands of study participants are required to improve the replicability of BWAS because actual effect sizes are much smaller than those reported in smaller studies. Here, we perform analyses and meta-analyses of a robust effect size index (RESI) using 63 longitudinal and cross-sectional magnetic resonance imaging studies from the Lifespan Brain Chart Consortium (77,695 total scans) to demonstrate that optimizing study design is critical for improving standardized effect sizes and replicability in BWAS. A meta-analysis of brain volume associations with age indicates that BWAS with larger covariate variance have larger effect size estimates and that the longitudinal studies we examined have systematically larger standardized effect sizes than cross-sectional studies. We propose a cross-sectional RESI to adjust for the systematic difference in effect sizes between cross-sectional and longitudinal studies that allows investigators to quantify the benefit of conducting their study longitudinally. Analyzing age effects on global and regional brain measures from the United Kingdom Biobank and the Alzheimer’s Disease Neuroimaging Initiative, we show that modifying longitudinal study design through sampling schemes to increase between-subject variability and adding a single additional longitudinal measurement per subject can improve effect sizes. However, evaluating these longitudinal sampling schemes on cognitive, psychopathology, and demographic associations with structural and functional brain outcome measures in the Adolescent Brain and Cognitive Development dataset shows that commonly used longitudinal models can, counterintuitively, reduce effect sizes. We demonstrate that the benefit of conducting longitudinal studies depends on the strengths of the between- and within-subject associations of the brain and non-brain measures. Explicitly modeling between- and within-subject effects avoids conflating the effects and allows optimizing effect sizes for them separately. These findings underscore the importance of considering study design features to improve the replicability of BWAS. ### Competing Interest Statement J.S., R.B., and A.A.B. are directors and hold equity in Centile Bioscience. A.A.B. receives consulting income from Octave Bioscience.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要